Filing Summary
Registrant: Blue Water Vaccines Inc., not Onconetix, Inc. The Form 8-K was filed December 6, 2022, with an earliest reported event date of December 6, 2022. The company is incorporated in Delaware, trades common stock under the symbol BWV on Nasdaq, and identifies as an emerging growth company.
Business Context and Reporting Period
The filing reports a Regulation FD disclosure under Item 7.01. The company furnished a presentation that it intended to use at a key opinion leader event scheduled for December 7, 2022.
Financial Metrics and Capital Position
The filing does not provide revenue, profit, cash flow, margins, debt, liquidity, operating results, or other financial metrics. No financial statements were included.
Material Changes Versus Prior Period
The filing does not disclose a material financial or operating change versus a prior comparable period. It only reports the planned investor or key opinion leader presentation.
Guidance, Outlook, Risks, and Unusual Items
- The presentation was furnished as Exhibit 99.1 and was not deemed filed for purposes of Section 18 of the Exchange Act.
- The presentation was not stated to be incorporated by reference into any Securities Act or Exchange Act filing.
- The filing text does not provide guidance, forecasts, risk updates, contingencies, or unusual accounting items.
Investor Verification Points
- Verify the issuer identity: the supplied filing names Blue Water Vaccines Inc., whereas the request metadata names Onconetix, Inc.
- Review Exhibit 99.1 for the underlying scientific, clinical, business, or strategic content presented at the December 7, 2022 event.
- Confirm that this filing contains no financial statements or quantitative performance disclosures.
- Note that the disclosure was furnished under Regulation FD and expressly received limited filing and incorporation-by-reference treatment.